Skip to main content

Regulatory & strategy

Articles  —  25 February Feb 2026

Mastering regulatory complexity: A Guide to derisking drug development in the US and Europe

Read More about Mastering regulatory complexity: A Guide to derisking drug development in the US and Europe
Articles  —  15 August Aug 2023

Lessons learned from missing the mark with FDA hot buttons

Read More about Lessons learned from missing the mark with FDA hot buttons
Articles  —  25 May May 2022

Providing Regulatory Support in China for a New Compound

Read More about Providing Regulatory Support in China for a New Compound
Articles  —  31 January Jan 2022

Safety First: Your Guide to the Toxic Substances Control ACT (TSCA)

Read More about Safety First: Your Guide to the Toxic Substances Control ACT (TSCA)
Articles  —  12 January Jan 2022

Intensive BMO Preparation is Key

Read More about Intensive BMO Preparation is Key
Articles  —  12 January Jan 2022

Avoiding Market Access Delay Due to Incorrect Product Classification Case Study

Read More about Avoiding Market Access Delay Due to Incorrect Product Classification Case Study
Articles  —  9 December Dec 2021

How Partnership Working Ensured a Colorful Future - Chemical Services Case Study

Read More about How Partnership Working Ensured a Colorful Future - Chemical Services Case Study
Articles  —  3 August Aug 2021

Endocrine Disruptors (ED): The Challenge of Accessing the ED Regulatory Framework

Read More about Endocrine Disruptors (ED): The Challenge of Accessing the ED Regulatory Framework
Articles  —  3 August Aug 2021

Navigating Nanomaterials Through REACH - Chemical Services Case Study

Read More about Navigating Nanomaterials Through REACH - Chemical Services Case Study
Articles  —  3 August Aug 2021

Nanomaterials: How to Overcome REACH Regulatory Challenges

Read More about Nanomaterials: How to Overcome REACH Regulatory Challenges
Articles  —  19 July Jul 2021

Estimate the Impact of Time Savings on Your Drug Development Program, Asset Value and Financial Company Performance

Read More about Estimate the Impact of Time Savings on Your Drug Development Program, Asset Value and Financial Company Performance
Articles  —  12 February Feb 2020

Pharmacovigilance Risk Management for Biosimilars

Read More about Pharmacovigilance Risk Management for Biosimilars
Articles  —  19 July Jul 2019

Creating Value - Compressing Time - Refining Burn Rate Forecasts: The Molecule Development Team (MDT)

Read More about Creating Value - Compressing Time - Refining Burn Rate Forecasts: The Molecule Development Team (MDT)
Articles  —  15 July Jul 2019

PVReview_Vol-9-1_MedicalLiteratureMonitoring_Sciformix_Desai.pdf

Read More about PVReview_Vol-9-1_MedicalLiteratureMonitoring_Sciformix_Desai.pdf
Articles  —  30 October Oct 2017

5466940-FLY-809808-01.indd

Read More about 5466940-FLY-809808-01.indd
Articles  —  12 May May 2017

Assessment of Abuse Liability of Brain-Penetrant Compounds: Regulatory Environment, Challenges and Opportunities in View of the Current Opioid Epidemic

Read More about Assessment of Abuse Liability of Brain-Penetrant Compounds: Regulatory Environment, Challenges and Opportunities in View of the Current Opioid Epidemic
Articles  —  25 April Apr 2017

Implementing a Proactive Approach to Risk Management

Read More about Implementing a Proactive Approach to Risk Management
Articles  —  10 June Jun 2015

Adaptive Trial Designs: Improving the Efficiency of Drug Development

Read More about Adaptive Trial Designs: Improving the Efficiency of Drug Development